Stroke
Conditions
Interventions
This is an observational, prospective study of follow-up and population analysis, longitudinal cohort type. Group of 50 patients after ischemic or hemorrhagic stroke who were discharged within 30 days
E02.760.169063500477500
Sponsors
Universidade Federal do Rio Grande do Norte - UFRN
Universidade Federal do Rio Grande do Norte - UFRN
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Adult and elderly patients will be included in the study; of both sexes; who are between the 1st and 30th day of discharge after an ischemic or hemorrhagic stroke; who do not show suggestive cognitive damage on the Mini-Mental State Examination (MMSE); in addition, those who have access to the internet and/or landline
Exclusion criteria
Exclusion criteria: Patients with a clinical diagnosis of a new stroke will be excluded from the study; and those with no telephone contacts.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Drug interactions were measured using the Drugdex system interactions in order to identify possible drug interactions and classify them as mild, moderate and severe. | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse reactions were measured through the Naranjo questionnaire, which seeks the causal relationship between the adverse reaction and the drug, and partial points will be assigned whose sum allows classifying ADRs in Definite; Likely; Possible; Doubtful;;Identify whether the pharmaceutical professional is included in the multidisciplinary team in providing care during and after hospital discharge of the post-stroke patient through an evaluation form organized in identification and general evaluation. Evaluate the negative drug results - RNM's in post-stroke patients, as well as their relationship with risk factors. | — |
Countries
Brazil
Contacts
Public ContactJair Júnior
Universidade Federal do Rio Grande do Norte - UFRN
Outcome results
None listed